Cargando…
The therapeutic potential of CRTH2/DP2 beyond allergy and asthma
Prostaglandin (PG) D(2) has been in the focus of research for quite a long time, but its biological effects and its roles in human disease are still not fully characterized. When in 2001 a second major PGD(2) receptor termed chemoattractant receptor homologue expressed on Th2 cells (CRTH2; alternati...
Autores principales: | Jandl, Katharina, Heinemann, Akos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612073/ https://www.ncbi.nlm.nih.gov/pubmed/28818625 http://dx.doi.org/10.1016/j.prostaglandins.2017.08.006 |
Ejemplares similares
-
Cross-talk of PGD(2) receptors: the DP receptor modulates signaling and trafficking of CRTH2
por: Sedej, Miriam, et al.
Publicado: (2010) -
Effects of PGH(2 )and PGD(2 )on CRTH2 and DP receptors in primary cells and co-expressed in HEK293 cells
por: Sedej, Miriam, et al.
Publicado: (2008) -
The D-type prostanoid (DP) receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)
por: Sedej, Miriam, et al.
Publicado: (2011) -
PGH(1), the Precursor for the Anti-Inflammatory Prostaglandins of the 1-series, Is a Potent Activator of the Pro-Inflammatory Receptor CRTH2/DP2
por: Schröder, Ralf, et al.
Publicado: (2012) -
Targeting the PGD(2)/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives
por: Kupczyk, Maciej, et al.
Publicado: (2017)